Demant 過去の業績

過去基準チェック /26

Demantは、平均年間15.5%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間成長しています。収益は、平均年間1.9% 10.9%収益成長率で成長しています。 Demantの自己資本利益率は26.7%であり、純利益率は11.1%です。

主要情報

15.5%

収益成長率

17.6%

EPS成長率

Medical Equipment 業界の成長	-9.5%
収益成長率	10.9%
株主資本利益率	26.7%
ネット・マージン	11.1%
前回の決算情報	30 Jun 2024

Recent updates

収支内訳

Demant の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

BATS-CHIXE:DEMANC 収益、費用、利益 ( )DKK Millions
日付	収益	収益	G+A経費	研究開発費
30 Jun 24	22,836	2,535	11,490	1,536
31 Mar 24	22,640	2,544	11,263	1,473
31 Dec 23	22,443	2,552	11,036	1,410
30 Sep 23	21,442	2,577	10,732	1,291
30 Jun 23	20,902	2,488	10,633	1,270
31 Mar 23	20,304	2,381	10,440	1,292
31 Dec 22	19,705	2,274	10,246	1,314
30 Sep 22	19,181	2,460	9,851	1,274
30 Jun 22	18,656	2,645	9,455	1,233
31 Mar 22	18,281	2,671	9,178	1,186
31 Dec 21	17,905	2,696	8,900	1,139
30 Sep 21	17,521	2,453	8,651	1,170
30 Jun 21	17,137	2,209	8,401	1,200
31 Mar 21	15,803	1,665	8,145	1,231
31 Dec 20	14,469	1,121	7,889	1,261
30 Sep 20	14,072	970	7,952	1,224
30 Jun 20	13,674	818	8,014	1,186
31 Mar 20	14,310	1,140	8,138	1,153
31 Dec 19	14,946	1,462	8,261	1,120
30 Sep 19	14,728	1,579	8,068	1,093
30 Jun 19	14,510	1,695	7,874	1,066
31 Mar 19	14,224	1,759	7,593	1,030
31 Dec 18	13,937	1,823	7,312	994
30 Sep 18	13,699	1,836	7,084	956
30 Jun 18	13,461	1,849	6,856	918
31 Mar 18	13,325	1,802	6,809	887
31 Dec 17	13,189	1,754	6,762	856
30 Sep 17	12,943	1,689	6,680	831
30 Jun 17	12,697	1,624	6,597	806
31 Mar 17	12,350	1,542	6,436	795
31 Dec 16	12,002	1,459	6,275	784
30 Sep 16	11,717	1,429	6,068	787
30 Jun 16	11,432	1,399	5,860	790
31 Mar 16	11,049	1,418	5,573	777
31 Dec 15	10,665	1,436	5,285	763
30 Sep 15	10,258	1,402	5,090	731
30 Jun 15	9,850	1,367	4,894	699
31 Mar 15	9,598	1,347	4,693	690
31 Dec 14	9,346	1,326	4,491	680
30 Sep 14	9,221	1,301	4,420	673
30 Jun 14	9,095	1,275	4,348	665
31 Mar 14	9,027	1,280	4,294	650
31 Dec 13	8,959	1,285	4,239	634

質の高い収益: DEMANCは高品質の収益を持っています。

利益率の向上: DEMANCの現在の純利益率 (11.1%)は、昨年(11.9%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: DEMANCの収益は過去 5 年間で年間15.5%増加しました。

成長の加速: DEMANCの過去 1 年間の収益成長率 ( 1.9% ) は、5 年間の平均 ( 年間15.5%を下回っています。

収益対業界: DEMANCの過去 1 年間の収益成長率 ( 1.9% ) Medical Equipment業界39.9%を上回りませんでした。

株主資本利益率

高いROE: DEMANCの自己資本利益率 ( 26.65% ) は高いですが、この指標は負債レベルが高いために歪んでいます。

Demant 過去の業績

過去 基準チェック /26

主要情報

最近の業績更新

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2020 earnings released: EPS kr.4.68 (vs kr.6.00 in FY 2019)

Recent updates

Demant A/S Appoints Anne-Karen Hunt as President of Diagnostics Business Area, Effective 1 November 2024

Demant A/S Announces Board Changes

Demant A/S Updates Earnings Guidance for the Year 2024

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2024

Investor sentiment improves as stock rises 21%

Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S

Less than half of directors are independent

Demant A/S to Report Nine Months, 2024 Results on Nov 04, 2024

Less than half of directors are independent

Demant A/S Provides Earnings Guidance for the Year 2023

Less than half of directors are independent

Now 21% undervalued

Demant A/S Announces Executive Changes

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Now 22% undervalued

Less than half of directors are independent

Less than half of directors are independent

Demant A/S to Report Fiscal Year 2022 Results on Feb 07, 2023

Less than half of directors are independent

Demant A/S Revised Earnings Guidance for the Full Year of 2022

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Demant A/S Revises Earnings Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Demant A/S (CPSE:DEMANT) acquired remaining 80% interest in ShengWang for CNY.

Less than half of directors are independent

Demant A/S Appoints Niels Wagner to the Board of Directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Demant A/S Announces Update on Voluntary Field Corrective Action

Less than half of directors are independent

Demant A/Sreiterated Guidance for the Year 2021

Less than half of directors are independent

Less than half of directors are independent

Demant A/S Updates Earnings Guidance for the Year 2021

Independent Director has left the company

Independent Director has left the company

New 90-day high: kr.263

Full year 2020 earnings released: EPS kr.4.68 (vs kr.6.00 in FY 2019)

Revenue beats expectations

Demant A/S Announces Executive Changes

New 90-day high: kr.237

Demant Launches New Flagship Hearing aids

New 90-day high: kr.235

Demant A/S, Annual General Meeting, Mar 05, 2021

Demant A/S Revises Earnings Guidance for the Second Half of Fiscal Year 2020

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /26